Trial Profile
Randomized phase II trial to outline the efficacy of gemcitabine containing regimens (gemcitabine/carboplatin and gemcitabine/paclitaxel) when used as preoperative chemotherapy in patients with stage I and II NSCLC
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2006
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Aug 2006 Status change
- 06 Nov 2005 New trial record.